Clinical Trials List
Protocol Number191622-094 AMEDNDMENT 2
2009-09-01 - 2014-07-31
Phase III
Terminated1
ICD-10G83.4
Cauda equina syndrome
ICD-9344.61
Cauda equina syndrome with neurogenic bladder
-
Trial Applicant
ALLERGAN PHARMACEUTICALS TAIWAN CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
500 participants
